Abstract:Objective. Interleukin-17 (IL-17)-producing T helper cells have been proposed to represent a separate lineage of CD4+ cells, designated Th17 cells, which are regulated by the transcription factor retinoic acid-related orphan receptor -gamma t (ROR gamma t). However, despite advances in understanding murine Th17 differentiation, a systematic assessment of factors that promote the differentiation of naive human T cells to Th17 cells has not been reported. The present study was undertaken to assess the effects on naive human CD4+ T cells of cytokines known to promote murine Th17 cells.Methods. Human naive and memory CD4+ T cells isolated from peripheral blood were activated and cultured with various cytokines. Cytokine production was measured by enzyme-linked immunosorbent assay and flow cytometry. Messenger RNA was measured by quantitative polymerase chain reaction.Results. In response to anti-CD3/anti-CD28 stimulation alone, human memory T cells rapidly produced IL-17, whereas naive T cells expressed low levels. Transforming growth factor beta 1 and IL-6 up-regulated ROR gamma t expression but did not induce Th17 differentiation of naive CD4+ T cells. However, IL-23 up-regulated its own receptor and was an important inducer of IL-17 and IL-22.Conclusion. The present data demonstrate the differential regulation of IL-17 and ROR gamma t expression in human CD4+ T cells compared with murine cells. Optimal conditions for the development of IL-17-producing T cells from murine naive precursors are ineffective in human T cells. Conversely, IL-23 promoted the generation of human Th17 cells but was also a very potent inducer of other proinflammatory cytokines. These findings may have important implications in the pathogenesis of human autoimmunity as compared with mouse models.

Suppression of Human and Mouse Th17 Differentiation and Autoimmunity by an Endogenous Interleukin 23 Receptor Cytokine-Binding Homology Region

Protection Against Th17 Cells Differentiation By An Interleukin-23 Receptor Cytokine-Binding Homology Region

Anti-inflammatory Effects of Interleukin-23 Receptor Cytokine-Binding Homology Region Rebalance T Cell Distribution in Rodent Collagen-Induced Arthritis

Human IL-23R Cytokine-Binding Homology Region-Fc Fusion Protein Ameliorates Psoriasis via the Decrease of Systemic Th17 and ILC3 Cell Responses

Interleukin-33 is Released in Spinal Cord and Suppresses Experimental Autoimmune Encephalomyelitis in Mice.

A Novel Human Truncated IL12rβ1-Fc Fusion Protein Ameliorates Experimental Autoimmune Encephalomyelitis Via Specific Binding of P40 to Inhibit Th1 and Th17 Cell Differentiation

Interleukin-23: as a drug target for autoimmune inflammatory diseases.

Interleukin‐23: As a Drug Target for Autoimmune Inflammatory Diseases

Regulation of IL-17 production in human lymphocytes

The regulatory mechanism and potential application of IL-23 in autoimmune diseases

Independent and Interdependent Immunoregulatory Effects of IL-27, IFN-β, and IL-10 in the Suppression of Human Th17 Cells and Murine Experimental Autoimmune Encephalomyelitis.

CTRP4/interleukin-6 receptor signaling ameliorates autoimmune encephalomyelitis by suppressing Th17 cell differentiation

Mouse Cd11b(+)Gr-1(+) Myeloid Cells Can Promote Th17 Cell Differentiation And Experimental Autoimmune Encephalomyelitis

Distinct Regulation of Interleukin-17 in Human T Helper Lymphocytes

Involvement of lncRNA-1700040D17Rik in Th17 cell differentiation and the pathogenesis of EAE.

Myeloid-derived Suppressive Cells Enhance Differentiation of Th17 Cells in an IL-1β Dependent Manner (P1096)

Disulfiram and Diphenhydramine Hydrochloride Upregulate Mir-30A to Suppress IL-17-Associated Autoimmune Inflammation

miR-20b Suppresses Th17 Differentiation and the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting RORγt and STAT3

Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt Protein

[Eukaryotic Expression of Human IL17-RD-ECD and Generation of Its Monoclonal Antibody].

MiR-384 Regulates the Th17/Treg Ratio during Experimental Autoimmune Encephalomyelitis Pathogenesis